Discontinuation Criteria

Discontinuation criteria are the conditions under which you must stop taking the medication if discomfort occurs after administration. For recurring digestive discomfort, changes in sleep, pulsating sensations, or skin reactions, stop taking the medication and then inquire.

For acute shortness of breath, edema, feeling of fainting, or severe chest pain, seek emergency medical evaluation immediately without waiting for a follow-up consultation appointment.

When can I make a general inquiry after stopping the medication?

If new discomfort occurs, such as recurring heartburn, diarrhea, pulsating sensations, insomnia, or rashes, but there are no emergency symptoms, stop taking the medication first and contact the dispensing institution. Please provide the time and dose of the last administration, when the discomfort began, any other medications taken together, and current remaining symptoms. Do not arbitrarily reduce the dose to continue taking it or switch to another product before your condition is verified.

When should I seek medical evaluation immediately?

For urgent symptoms such as shortness of breath, swelling of the lips, tongue, or throat, feeling of fainting, severe chest pain, or changes in consciousness, do not wait for a response to a general inquiry. You should also be evaluated at a medical institution first if you cannot maintain hydration due to severe vomiting or diarrhea, or if symptoms worsen rapidly.

How is the criteria for restarting the medication determined?

Do not restart the same product on your own simply because the discomfort has disappeared. The decision to resume is made after verifying the ingredients, dosage, interactions with other medications, and the possibility of allergies. The FDA advises confirming in advance when to stop a medication and whom to notify if adverse reactions occur.

• FDA: Safety principles for monitoring efficacy and adverse reactions during administration